BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3493659)

  • 1. Diagnosis and staging of renal cell carcinoma: a comparison of MR imaging and CT.
    Fein AB; Lee JK; Balfe DM; Heiken JP; Ling D; Glazer HS; McClennan BL
    AJR Am J Roentgenol; 1987 Apr; 148(4):749-53. PubMed ID: 3493659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staging and differential diagnosis of renal cell carcinoma: a comparison of magnetic resonance imaging (MRI) and computed tomography (CT).
    Nishimura K; Hida S; Okada K; Yoshida O; Nishimuara K
    Hinyokika Kiyo; 1988 Aug; 34(8):1323-31. PubMed ID: 3195400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging in the diagnosis and staging of renal and perirenal neoplasms.
    Hricak H; Demas BE; Williams RD; McNamara MT; Hedgcock MW; Amparo EG; Tanagho EA
    Radiology; 1985 Mar; 154(3):709-15. PubMed ID: 3969475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The staging of renal-cell carcinomas in MRT and CT--a prospective histologically controlled study].
    Hallscheidt P; Stolte E; Roeren T; Pomer S; Drehmer I; Kauffmann GW
    Rofo; 1998 Feb; 168(2):165-70. PubMed ID: 9519049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nuclear spin tomography and computerized tomography in malignant hypernephroma].
    Uhlenbrock D; Fischer C; Rühl G; Beyer HK; Hummelsheim P
    Rofo; 1987 Jun; 146(6):664-74. PubMed ID: 3037637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of gadolinium (Gd-DTPA) in the staging of renal carcinoma using magnetic resonance. Comparative evaluation with computerized tomography and magnetic resonance without contrast media].
    De Cobelli F; Vanzulli A; Colombo E; Bonato C; Sironi S; Del Maschio A
    Radiol Med; 1993 May; 85(5):562-9. PubMed ID: 8327756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of MR imaging and CT in the evaluation of renal masses.
    Amendola MA
    Crit Rev Diagn Imaging; 1989; 29(2):117-50. PubMed ID: 2540936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of T2-weighted MR imaging in differentiating low-fat renal angiomyolipomas from other renal tumors.
    Choi HJ; Kim JK; Ahn H; Kim CS; Kim MH; Cho KS
    Acta Radiol; 2011 Apr; 52(3):349-53. PubMed ID: 21498374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging of the kidneys and adrenal glands.
    Baumgartner BR; Chezmar JL
    Semin Ultrasound CT MR; 1989 Feb; 10(1):43-62. PubMed ID: 2697325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and staging of renal neoplasms: a reassessment of MR imaging.
    Hricak H; Thoeni RF; Carroll PR; Demas BE; Marotti M; Tanagho EA
    Radiology; 1988 Mar; 166(3):643-9. PubMed ID: 3340757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical value of new rapid nuclear magnetic resonance tomography in preoperative assessment of hypernephroma. A prospective comparative study of CT and MR].
    Vorreuther R; Krestin GP; Franzen W; Engelking R; Friedmann G
    Urologe A; 1990 Jan; 29(1):39-42. PubMed ID: 2316079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiomyolipoma: imaging findings in lesions with minimal fat.
    Jinzaki M; Tanimoto A; Narimatsu Y; Ohkuma K; Kurata T; Shinmoto H; Hiramatsu K; Mukai M; Murai M
    Radiology; 1997 Nov; 205(2):497-502. PubMed ID: 9356635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characterization and staging of renal tumors: significance of MRI diagnostics].
    Kalinka A; Gerlach A; Arlart IP; Günes N; Hauser TK; Würstlin S; Bosse A
    Rofo; 2006 Mar; 178(3):298-305. PubMed ID: 16508837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The importance of magnetic resonance tomography in the diagnosis and staging of renal cell carcinoma].
    Krestin GP; Gross-Fengels W; Marincek B
    Radiologe; 1992 Mar; 32(3):121-6. PubMed ID: 1565792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal adenocarcinoma: CT staging of 100 tumors.
    Johnson CD; Dunnick NR; Cohan RH; Illescas FF
    AJR Am J Roentgenol; 1987 Jan; 148(1):59-63. PubMed ID: 3491524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodality approach to staging renal cell carcinoma.
    Fritzsche PJ; Millar C
    Urol Radiol; 1992; 14(1):3-7. PubMed ID: 1615571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osseous metastasis from renal cell carcinoma: "flow-void" sign at MR imaging.
    Choi JA; Lee KH; Jun WS; Yi MG; Lee S; Kang HS
    Radiology; 2003 Sep; 228(3):629-34. PubMed ID: 12881586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiology in the diagnosis and staging of renal cell carcinoma.
    Zagoria RJ; Dyer RB; Wolfman NT; Hinn GC; Chen YM
    Crit Rev Diagn Imaging; 1990; 31(1):81-115. PubMed ID: 2288659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of magnetic resonance on staging of renal carcinoma.
    Ramchandani P; Soulen RL; Schnall RI; Seidmon EJ; Friedman AC; Radecki PD; Caroline DF
    Urology; 1986 Jun; 27(6):564-8. PubMed ID: 3521049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unenhanced CT and MRI Parameters That Can Be Used to Reliably Predict Fat-Invisible Angiomyolipoma.
    Jeong CJ; Park BK; Park JJ; Kim CK
    AJR Am J Roentgenol; 2016 Feb; 206(2):340-7. PubMed ID: 26797361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.